Lyra Therapeutics, Inc.·4

Feb 1, 4:15 PM ET

Bishop John E 4

4 · Lyra Therapeutics, Inc. · Filed Feb 1, 2024

Insider Transaction Report

Form 4
Period: 2024-01-30
Bishop John E
Chief Technology Officer
Transactions
  • Award

    Stock Options

    2024-01-30+200,000200,000 total
    Exercise: $4.58Exp: 2034-01-29Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 30, 2024.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4